Mankind Pharma Limited

• Mankind Pharma management will host an earnings conference call on October 26, 2026. • The call will discuss business and financial results for Q2 and H1 FY27 periods. • This intimation is made purs

Mankind Pharma board meeting scheduled for October 26, 2026 to approve Q2 FY27 financial results. Trading window closure extended until October 28, 2026 per insider trading regulations. Disclosure mad